View in EDS

LBA33 ICON9: International phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy

Saved in:
Bibliographic Details
Title: LBA33 ICON9: International phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
Authors: Nicum, S.1 (AUTHOR), Ledermann, J.A.2 (AUTHOR), Mileshkin, L.3 (AUTHOR), Jayson, G.C.4 (AUTHOR), Gourley, C.5 (AUTHOR), Michael, A.6 (AUTHOR), Lord, R.7 (AUTHOR), Mackay, H.8 (AUTHOR), Hall, M.9 (AUTHOR), Tookman, L.10 (AUTHOR), Banerjee, S.11 (AUTHOR), Harnett, P.12 (AUTHOR), Macdonald, I.13 (AUTHOR), Lee, Y.C.14 (AUTHOR), Elyashiv, O.13 (AUTHOR), Wilkinson, K.15 (AUTHOR), Farrelly, L.16 (AUTHOR), Counsell, N.17 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1225-S1226. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 179693602
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: LBA33 ICON9: International phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Nicum%2C+S%2E%22">Nicum, S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ledermann%2C+J%2EA%2E%22">Ledermann, J.A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mileshkin%2C+L%2E%22">Mileshkin, L.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jayson%2C+G%2EC%2E%22">Jayson, G.C.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gourley%2C+C%2E%22">Gourley, C.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Michael%2C+A%2E%22">Michael, A.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lord%2C+R%2E%22">Lord, R.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mackay%2C+H%2E%22">Mackay, H.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hall%2C+M%2E%22">Hall, M.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tookman%2C+L%2E%22">Tookman, L.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Banerjee%2C+S%2E%22">Banerjee, S.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Harnett%2C+P%2E%22">Harnett, P.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Macdonald%2C+I%2E%22">Macdonald, I.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee%2C+Y%2EC%2E%22">Lee, Y.C.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Elyashiv%2C+O%2E%22">Elyashiv, O.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wilkinson%2C+K%2E%22">Wilkinson, K.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Farrelly%2C+L%2E%22">Farrelly, L.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Counsell%2C+N%2E%22">Counsell, N.</searchLink><relatesTo>17</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS1225-S1226. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179693602
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2024.08.2272
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S1225
    Titles:
      – TitleFull: LBA33 ICON9: International phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nicum, S.
      – PersonEntity:
          Name:
            NameFull: Ledermann, J.A.
      – PersonEntity:
          Name:
            NameFull: Mileshkin, L.
      – PersonEntity:
          Name:
            NameFull: Jayson, G.C.
      – PersonEntity:
          Name:
            NameFull: Gourley, C.
      – PersonEntity:
          Name:
            NameFull: Michael, A.
      – PersonEntity:
          Name:
            NameFull: Lord, R.
      – PersonEntity:
          Name:
            NameFull: Mackay, H.
      – PersonEntity:
          Name:
            NameFull: Hall, M.
      – PersonEntity:
          Name:
            NameFull: Tookman, L.
      – PersonEntity:
          Name:
            NameFull: Banerjee, S.
      – PersonEntity:
          Name:
            NameFull: Harnett, P.
      – PersonEntity:
          Name:
            NameFull: Macdonald, I.
      – PersonEntity:
          Name:
            NameFull: Lee, Y.C.
      – PersonEntity:
          Name:
            NameFull: Elyashiv, O.
      – PersonEntity:
          Name:
            NameFull: Wilkinson, K.
      – PersonEntity:
          Name:
            NameFull: Farrelly, L.
      – PersonEntity:
          Name:
            NameFull: Counsell, N.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2024 Supplement 2
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 35
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1